Beverly L. Falcón - Concepedia

Author

Beverly L. Falcón

Also Known As

B Falcon, B. Falcon, BEVERLY FALCON, BEVERLY L. FALCON, Beverly Falcon, Beverly Falcón, Beverly L Falcon, Beverly L. Falcon, Beverly L. Falcón, Beverly L. Falcón

136

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of California, San Francisco Amgen (United States)Cornell University University of Florida

About

Beverly L. Falcón is an author at Eli Lilly (United States) specializing in medicine, tumor microenvironment, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.2K
2	Immunology	5	5	708
3	Cell Biology	4	4	673
4	Health Sciences	3	3	414
5	Gastroenterology	1	1	35

Beverly L. Falcón

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer Weon‐Kyoo You, Barbara Sennino, Casey W. Williamson, Cancer Research Angiogenesis InhibitorsImmunologyBlock Vegf ReceptorPathologyTumor Biology	2011	258
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity Louis J. Aronne, Deborah B. Horn, Carel W. le Roux, New England Journal of Medicine	2025	250
Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth Hiroya Hashizume, Beverly L. Falcón, Takashi Kuroda, Cancer Research ImmunologyTumor BiologyTumor AngiogenesisAngiogenesisAnti-cancer Agent	2010	246
Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels Beverly L. Falcón, Hiroya Hashizume, Petros Koumoutsakos, American Journal Of Pathology ThrombosisOncologyAngiogenesisMedicineEndothelial Dysfunction	2009	218
Sequential Loss of Tumor Vessel Pericytes and Endothelial Cells after Inhibition of Platelet-Derived Growth Factor B by Selective Aptamer AX102 Barbara Sennino, Beverly L. Falcón, Dilara McCauley, Cancer Research	2007	153
Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody Angela Coxon, James Bready, Hosung Min, Molecular Cancer Therapeutics AngiogenesisContext-dependent RoleAng1 NeutralizationTumor GrowthImmunology	2010	148
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial Rachel Kerr, Sharon Love, Eva Segelov, The Lancet Oncology Gastrointestinal OncologyMedicineAdjuvant CapecitabineClinical TrialsColorectal Cancer	2016	147
Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors Beverly L. Falcón, Sharon Barr, Prafulla C. Gokhale, Cancer Research	2011	91
The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma Caitlin D. Lowery, Alle B. VanWye, Michele Dowless, Clinical Cancer Research	2017	65
Increased Vascular Delivery and Efficacy of Chemotherapy after Inhibition of Platelet-Derived Growth Factor-B Beverly L. Falcón, Kristian Pietras, Jeyling Chou, American Journal Of Pathology ThrombopoiesisThrombosisVascular DeliveryBlood PlateletMedicine	2011	51

Page 1